Tyler Bussian
Stock Analyst at Brookline Capital
(0.17)
# 4,213
Out of 4,876 analysts
5
Total ratings
25%
Success rate
-22.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.53 | +488.24% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $6.05 | +941.32% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $0.70 | +1,328.57% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $2.05 | +339.02% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.53
Upside: +488.24%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $6.05
Upside: +941.32%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.70
Upside: +1,328.57%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.05
Upside: +339.02%